Abstract
1157 GQ1007: the next generation HER2-targeting antibody immune agonist conjugate with robust efficacy and favorable safety profile
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1136/jitc-2023-sitc2023.1157
Journal: Journal for ImmunoTherapy of Cancer | Publication Date: Nov 1, 2023 |
License type: CC BY-NC 4.0 |
1157 GQ1007: the next generation HER2-targeting antibody immune agonist conjugate with robust efficacy and favorable safety profile
Join us for a 30 min session where you can share your feedback and ask us any queries you have